Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer

BACKGROUND: We investigated the prognostic impact of changes in serum CA125 levels during the first 3 months of therapy in ovarian cancer. METHODS: A case series of 170 ovarian cancer patients treated at Cancer Treatment Centers of America. Based on CA125 levels at baseline and 3 months, patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Digant, Lammersfeld, Carolyn A, Vashi, Pankaj G, Braun, Donald P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959041/
https://www.ncbi.nlm.nih.gov/pubmed/20939881
http://dx.doi.org/10.1186/1757-2215-3-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959041/
https://www.ncbi.nlm.nih.gov/pubmed/20939881
http://dx.doi.org/10.1186/1757-2215-3-22

Ejemplares similares